• Sokabe H, Mizogami S, Murase T, and Sakai F: Renin and euryhalinity in the Japanese eel, Anguilla Japonica. Nature 212: 952-953, 1966.
• Murase T, and Yoshida S: Effect of hypotension on levels of antidiuretic hormone in plasma in dogs. Endocrinol Japon 18: 215-219, 1971.
• Murase T, and Yoshida S: Mechanism of chlorpropamide action in patients with diabetes insipidus. J Clin Endocrinol Metab 36: 174-177, 1973.
• Murase T, Mukoyama A, Ohsawa N, Nagataki S, Yamaji T, and Tsushima T: A survival case of myxedema coma of pituitary origin. Endocrinol Japon 21: 331-334, 1973.
• Murase T, Ikeda H, Muro T, Nakao K, and Sugita H: Myopathy associated with type III glycogenosis. J Neurol Sci 20: 287-295, 1973.
• Murase T, Cattran DC, Rubenstein B, and Steiner G: Inhibition of lipoprotein lipase by uremic plasma: a possible cause of hypertriglyceridemia. Metabolism 24: 1279-1286, 1975.
• Steiner G, and Murase T: Triglyceride turnover: a comparison of simultaneous determinations using the radioglyceride and the lipolytic rate procedures. Fed Proc 34: 2258-2262, 1975.
• Shimamoto K, Murase T, and Yamaji T: A heterologous radioimmunoassay for arginine vasopressin. J Lab Clin Med 87: 338-344, 1976.
• Yokoyama S, Murase T, and Akanuma Y: Phosphatidylcholine substrate specificity of lecithin:cholesterol acyltransferase in high density lipoproteins and lipid dispersions. J Biochem 82: 719-724, 1977.
• Yokoyama S, Murase T, and Akanuma Y: The interaction of apolipoproteins with lecithin: cholesterol acyltransferase. Biochim Biophys Acta 530: 258-266, 1978.
• Yamada N, Murase T, Akanuma Y, Itakura H, and Kosaka K: A selective deficiency of hepatic triacylglycerol lipase in guinea pigs. Biochim Biophys Acta 575: 128-134, 1979.
• Murase T, Yamada N, Ohsawa N, Kosaka, K, Morita S, and Yoshida S: Decline of postheparin plasma lipoprotein lipase in acromegalic patients. Metabolism 29: 666-672, 1980.
• Murase T, and Uchimura H: A selective decline of postheparin plasma hepatic triglyceride lipase in hypothyroid rats. Metabolism 29: 797-801, 1980.
• Yamada N, and Murase T: Modulation, by apolipoprotein E, of lipoprotein lipase activity. Biochem Biophys Res Commun 94: 710-715, 1980.
• Kondo Y, Miyazono Y, Katayama S, Murase T, Yamaji T, Ohsawa N, and Kosaka K: Inappropriate secretion of antidiuretic hormone in nude mice bearing a human bronchogenic oat cell carcinoma. Cancer Res 41: 1545-1548, 1981.
• Murase T, Yamada N, and Matsuzaki F: The in vitro effect of growth hormone on adipose tissue lipoprotein lipase in rats. Life Sci 28: 199-201, 1981.
• Yamada N, Murase, T, Akanuma Y, Itakura H, and Kosaka K: Ascities chylomicron: a poor substrate for hepatic triglyceride lipase. Clin Chim Acta 110: 45-49, 1981.
• Murase T, Tanaka K, Iwamoto Y, Akanuma Y, and Kosaka K: Reciprocal changes, caused by insulin and glucagon, of adipose tissue lipoprotein lipase in rats in vitro. Horm Metab Res 13: 212-213, 1981.
• Murase T, and Itakura H: Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats. Atherosclerosis 39: 293-300, 1981.
• Inoue S, and Murase T: Increase of postheparin plasma-lipoprotein-lipase activity in ventromedial-hypothalamic obesity in rats. Int J Obesity 6: 259-266, 1982.
• Yamada N, Murase T, Akanuma Y, Itakura H, and Kosaka K: Plasma apolipoprotein E levels in hypertriglyceridemia. Horm Metab Res 14: 303-306, 1982.
• Sakuma M, Akanuma Y, Kodama T, Yamada N, Murata S, Murase T Itakura H, and Kosaka, K: Familial plasma lecithin:cholesterol acyltransferase deficiency. Acta Med Scand 212: 225-232, 1982.
• Murase T, Yamada N, Akanuma Y, and Ohsawa N: Triacylglycerol lipases in adrenals and testes of rat. J Biochem 92: 817-821, 1982.
• Ishikawa A, Murase T, Yamada N, Tanaka K, Iwamoto Y, Akanuma Y, and Ohsawa N: Lipoprotein lipase activity in adipose tissue of streptozotocin-induced diabetic rats. Endocrinol Jap 29: 379-381, 1982.
• Murase T, Yamada N, and Uchimura H: Accumulation of intermediate density lipoprotein in the plasma of cholesterol-fed hypothyroid rats. Metabolism 32: 146-150, 1983.
• Go T, Ohkubo H, Mochizuki Y, Murase T, and Yamada N: Primary type I hyperlipoproteinemia: Significance of lipoprotein lipase and hepatic triglyceride lipase activity in heterozygotes of patients with familial lipoprotein lipase deficiency. J Pediatr 102: 405-407, 1983.
• Itakura H, Murase T, and Takaku F: Hepatic triglyceride lipase activity in plasma of patients with fatty liver, after treatment with heparin. Clin Chem 29: 726-727, 1983.
• Kodama T, Murase T, Itakura H, Akanuma Y, Takaku F, and Nishida Y: Postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities in patients with primary asymptomatic gout. Clin Chem 29: 2124, 1984.
• Murayama N, Asano Y, Kato K, Sakamoto Y, Hosoda S, Yamada N, Kodama T, Murase T, and Akanuma Y: Effects of plasma infusion on plasma lipids, apoproteins and plasma enzyme activities in familial lecithin: cholesterol acyltransferase deficiency. Europ J Clin Invest 14: 122-129, 1984.
• Takahashi K, Murase T, Yamada N, Iwamoto Y, Akanuma Y, and Takaku F: Plasma lipoproteins in Streptozotocin-diabetic rats, after Triton WR-1339 treatment. Horm Metab Res 16: Suppl 82-84, 1984.
• Yamada N, Murase T, Iwamoto Y, Mashiko S, and Akanuma Y: Reciprocal changes of plasma apo AI and apo E levels in Streptozotocin-induced diabetic rats. Horm Metab Res 16: Suppl 85-88, 1984.
• Mori N, Murase T, Yamada N, Arakawa N, and Takaku F: Wide variations of plasma triglyceride concentrations in guinea pigs. Lipids 19: 978-981, 1984.
• Okabe T, Yorifuji H, Murase T, and Takaku F: Pulmonary macrophage: A major source of lipoprotein lipase in the lung. Biochem Biophys Res Commun 125: 273-278, 1984.
• Murase T, and Inoue S: Hepatic triglyceride lipase is not an insulin-dependent enzyme in rats. Metabolism 34: 531-534, 1985.
• Sato S, Inoue S, Egawa M, Takamura Y, and Murase T: Increased triglyceride secretion rate and hyperinsulinemia in ventromedial hypothalamic lesioned rats. Acta Endocrinol 110: 6-9, 1985.
• Nakai T, Oida K, Kutsumi Y, Hayashi T, Miyabo S, Takeda R, Yamada N, and Murase T: Effects of insulin on hypercholesterolemia in the streptozotocin-induced diabetic rats fed a high cholesterol diet. Artery 13: 61-76, 1985.
• Ishibashi S, Murase T, Yamada N, Tanaka K, Takaku F, and Sato K: Hyperlipidaemia in patients with hypopituitarism. Acta Endocrinol 110: 456-460, 1985.
• Murase T, Oka T, Yamada N, Mori N, Ishibashi S, Takaku F, and Mori W: Immunohistochemical localization of apolipoprotein E in atherosclerotic lesions of the aorta and coronary arteries. Atherosclerosis 60: 1-6, 1986.
• Ishibashi S, Murase T, Takahashi K, Mori N, Kawakami M, and Takaku F: Plasma apolipoprotein CII levels in hypertriglyceridemia. Metabolism 35: 781-785, 1986.
• Kawakami M, Murase T, Itakura H, Yamada H, Ohsawa N, and Takaku F: Lipid metabolism in endotoxic rats: Decrease in hepatic triglyceride lipase activities. Microbiol Immunol 30: 849-854, 1986.
• Kawakami M, Murase T, Ishibashi S, Mori N, and Takaku F: Lipoprotein lipase in mice peritoneal macrophages: The effects of insulin and dexamethasone. J Biochem 100: 1373-1378, 1986.
• Kawakami M, Ishibashi S, Ogawa H, Murase T, Takaku F, and Shibata S: Cachectin/TNF as well as interleukin 1 induces prostacyclin synthesis in cultured vascular endothelial cells. Biochem Biophys Res Commun 141: 482-487, 1986.
• Kawakami M, Murase T, Ogawa H, Ishibashi S, Mori N, Takaku F, and Shibata S: Human recombinant TNF suppresses lipoprotein lipase and stimulates lipolysis in 3T3-L1 cells. J Biochem 101: 331-338, 1987.
• Mori N, Yamada N, Ishibashi S, Kawakami M, Takahashi K, Shimano H, Fujisawa M, Takaku F, and Murase T: High-cholesterol diet-induced lipoproteins stimulate lipoprotein lipase secretion in cultured rat alveolar macrophages. Biochim Biophys Acta 922: 103-110, 1987.
• Aburatani H, Murase T, Takaku F, Itoh H, Matsumoto A, and Itakura H: Apolipoprotein B-gene polymorphism and myocardial infarction. N Engl J Med 317: 52, 1987.
• Satoh S, Inoue S, Egawa M, Takamura Y, and Murase T: Insulin increases triglyceride secretion rate in rats in vivo. Int J Obes 11: 325-331, 1987.
• Nakanishi K, Kobayashi T, Sugimoto T, Murase T, Itoh T, and Kosaka K: Does pan-pancreatic involvement occur in IDDM? Diabetes Care 11: 100-101, 1988.
• Aburatani H, Matsumoto A, Itoh H, Murase T, Takaku F, and Itakura H: Deoxyribonucleic acid (DNA) polymorphism in the apolipoprotein AI gene: A study in a Japanese population. Jpn J Med 27: 56-59, 1988.
• Aburatani H, Matsumoto A, Itoh H, Yamada N, Murase T, Takaku F, and Itakura H: A study of DNA polymorphism in the apolipoprotein B gene in a Japanese population. Atherosclerosis 72: 71-76, 1988.
• Ishibashi S, Yamada N, Oka Y, Shimano H, Mori N, Yoon TH, Shimada M, Kanazawa Y, Akanuma Y, Murase T, and Takaku F: Enhanced synthesis and secretion of apolipoprotein E from sciatic nerves of streptozotocin-induced diabetic rats after injury. Biochem Biophys Res Commun 155: 283-288, 1988.
• Shimano H, Aburatani H, Mori N, Ishibashi S, Gotoda T, Mokuno H, Kawakami M, Akanuma Y, Takaku F, Murase T, and Yamada N: Down-regulation of hepatic LDL receptor protein and messenger RNA in fasted rabbits. J Biochem 104: 712-716, 1988.
• Nakanishi K, Kobayashi T, Sugimoto T, Murase T, Itoh T, and Kosaka K: Predictive value of insulin autoantibodies for further progression of β-cell dysfunction in non-insulin-dependent diabetics. Diabetes Res 9: 105-109, 1988.
• Kobayashi T, Nakanishi K, Sugimoto T, Itoh T, Murase T, Kosaka K, and Tsuji K: Maleness as risk factor for slowly progressive IDDM. Diabetes Care 12: 7-11, 1989.
• Kawakami M, Watanabe N, Ogawa H, Kato A, Sando H, Yamada N, Murase T, Takaku F, Shibata S, and Oda T: Cachectin/TNF kills or inhibits the differentiation of 3T3-L1 cells according to developmental stage. J Cellular Physiol 138: 1-7, 1989.
• Yamada N, Shimano H, Mokuno H, Ishibashi S, Gotoda T, Kawakami M, Watanabe Y, Akanuma Y, Murase T, and Takaku F: Increased clearance of plasma cholesterol after injection of apolipoprotein E into Watanabe heritable hyperlipidemic rabbits. Proc Nat1 Acad Sci USA 86: 665-669, 1989.
• Ohno M, Ishibashi S, Nakao K, Nozue T, Nonomura K, Yamada N, Aburatani H, Shimano H, and Murase T: A neonatal case of apolipoprotein C-II deficiency. Eur J Pediatr 148: 550-552, 1989.
• Gotoda T, Senda M, Murase T, Yamada N, Takaku F, and Furuichi Y: Detection of familial LPL deficiency by PvuII RFLP. Nucleic Acids Res 17: 3607, 1989.
• Ishibashi S, Yamada N, Shimano H, Takaku F, Akanuma Y, and Murase T: Composition of very-low-density lipoproteins in non-insulin-dependent diabetes mellitus. Clin Chem 35: 808-812, 1989.
• Shimano H, Ishibashi S, Murase T, Gotoda T, Yamada N, Takaku F, and Ohtomo E: Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 79: 257-260, 1989.
• Ishibashi S, Mori N, Murase T, Shimano H, Gotoda T, Kawakami M, Akanuma Y, Takaku F, and Yamada N: Enhanced lipoprotein lipase secretion from human monocyte-derived macrophages caused by hypertriglyceridemic very low density lipoproteins. Arteriosclerosis 9: 650-655, 1989.
• Gotoda T, Senda M, Murase T, Yamada N, Takaku F, and Furuichi Y: Gene polymorphism identified by PvuII in familial lipoprotein lipase deficiency. Biochem Biophys Res Commun 164: 1391-1396, 1989.
• Mori N, Aoyama H, Murase T, and Mori W: Anti-hypercholesterolemic effect of melatonin in rats. Acta Pathol Jpn 39: 613-618, 1989.
• Kawakami K, Tsukada A, Okubo M, Tsukada T, Kobayashi T, Yamada N, and Murase T: A rapid electrophoretic method for the detection of serum Lp(a) lipoprotein. Clin Chim Acta 185: 147-156, 1989.
• Ishibashi S, Yamada N, Shimano H, Mori N, Mokuno H, Gotoda T, Kawakami M, Murase T, and Takaku F: Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. J Biol Chem 265: 3040-3047, 1990.
• Mokuno H, Yamada N, Sugimoto T, Kobayashi T, Ishibashi S, Shimano H, Takizawa M, Kawakami M, Takaku F, and Murase T: Cholesterol-free diet with a high ratio of polyunsaturated to saturated fatty acids in heterozygous familial hypercholesterolemia. Horm Metab Res 22: 246-251, 1990.
• Yamada N, Murase T, Shimano H, Gotoda T, Harada K, and Takaku F: Effect on plasma cholesterol of a step 1 diet with or without increased monounsaturated fats. N Engl J Med 323: 274, 1990.
• Kobayashi T, Nakanishi K, Kajio H, Morinaga S, Sugimoto T, Murase T, and Kosaka K: Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33: 363-370, 1990.
• Nakanishi K, Kobayashi T, Miyashita H, Ohkubo M, Sugimoto T, Murase T, Kosaka K, Inoue K, and Kono M: Relationships among islet cell antibodies, residual β-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay. Metabolism 39: 925-930, 1990.
• Yoon TH, Yamada N, Ishibashi S, Shimano H, Gotoda T, Harada K, Akanuma Y, Murase T, and Takaku F: The release of hepatic triglyceride lipase from rat monolayered hepatocytes in primary culture. Endocrinol Japon 37: 437-442, 1990.
• Kawakami M, Kondo Y, Imai Y, Hashiguchi M, Ogawa H, Hiragun A, Aotsuka S, Shibata S, Oda T, Murase T, and Takaku F: Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line. J Biochem 109: 78-82, 1991.
• Murase T, Okubo M, and Hara M: Does chylomicronemia cause atherosclerosis? Tohoku J Exp Med 163: 129-134, 1991.
• Shimano H, Yamada N, Ishibashi S, Mokuno H, Mori N, Gotoda T, Harada K, Akanuma Y, Murase T, Yazaki Y, and Takaku F: Oxidation-labile subfraction of human plasma low density lipoprotein isolated by ion-exchange chromatography. J Lipid Res 32: 763-773, 1991.
• Gotoda T, Yamada N, Murase T, Sakuma M, Murayama N, Shimano H, Kozaki K, Albert J J, Yazaki Y, and Akanuma Y: Different phenotypic expression by three mutant alleles in familial lecithin: cholesterol acyltransferase deficiency. Lancet 338: 778-781, 1991.
• Gotoda T, Yamada N, Kawamura M, Kozaki K, Mori N, Ishibashi S, Shimano H, Takaku, Yazaki Y, Furuichi Y, and Murase T: Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest 88: 1856-1864, 1991.
• Gotoda T, Yamada N, Murase T, Inaba T, Ishibashi S, Shimano H, Koga S, Yazaki Y, Furuichi Y, and Takaku F: Occurrence of multiple aberrantly spliced mRNAs upon a donor splice site mutation that causes familial lipoprotein lipase deficiency. J Biol Chem 266: 24757-24762, 1991.
• Yamazaki T, Katoh K, Nakanishi S, Nishiyama S, Seki A, Okubo, M, and Murase T: Prediction of the severity of coronary artery disease by measurement of lipoprotein(a). Coron Artery Dis 3: 57-60, 1992.
• Kajio H, Kobayashi T, Hara M, Nakanishi K, Sugimoto T, Murase, T, Akanuma, Y, Kosaka, K, Shibasaki, Y, Kasuga, M, Yamada, N, and Yazaki, Y: Islet amyloid polypeptide (IAPP) gene analysis in a Japanese diabetic with marked islet amyloid deposition. Diab Res Clin Pract 15: 45-48, 1992.
• Kobayashi T, Ito Y, Nakanishi K, Sugawara K, Okubo M, Sugimto T, Murase T, and Kosaka K: Relationship between islet amyroid polypeptide (IAPP) deposition and insulin reponse and beta-cell volume in diabetes mellitus. Diab Res Clin Pract 15: 15-16, 1992.
• Gotoda T, Yamada N, Murase T, Miyake S, Murakami R, Kawamura M, Kozaki N, Mori N, Shimano H, Shimada M, and Yazaki Y: A newly identified null allelic mutation in the human lipoprotein lipase (LPL) gene of a compound heterozygote with familial LPL deficiency. Biochim Biophys Acta 1138: 353-356, 1992.
• Hiraga T, Harada K, Kobayashi T, and Murase T: Reduction of serum lipoprotein (a) using estrogen in a man with familial hypercholesterolemia. JAMA 267 (17): 2328, 1992.
• Shimano H, Yamada N, Katsuki M, Shimada M, Gotoda T, Harada K, Murase T, Fukazawa C, Takaku F, and Yazaki Y: Overexpression of apolipoprotein E in transgenic mice: Marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. Proc Nat1 Acad Sci USA 89: 1750-1754, 1992.
• Gotoda T, Yamada N, Murase T, Shimano H, Shimada M, Harada K, Kawamura M, Kozaki K, and Yazaki Y: Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion. J Lipid Res 33: 1067-1072, 1992.
• Kobayashi T, Nakanishi K, Murase T, and Kosaka K: Difference between islet all antibodies and autoantibodies to glutamic and decarboxylase-containing Purkinje cells in IDDM. Diabetes Care 15: 1435-1436, 1992.
• Kobayashi T, Nakanishi K, Murase T, and Kosaka K: Subtype of islet cell antibodies and slowly progressive beta-cell failure. Diabetologia 36: 92, 1993.
• Nakanishi K, Kobayashi T, Miyashita H, Okubo M, Sugimoto T, Murase T, Kosaka K, and Hara M: Relationships among residual β-cell, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus. Metabolism 42: 196-203, 1993.
• Sugawara K, Kobayashi T, Nakanishi K, Kajio H, Okubo M, Sugimoto T, Murase T, Itoh T, Hara M, and Kosaka K: Marked islet amyloid polypeptide-positive amyloid deposition: a possible cause of secondary failure of oral hypoglycemic agents. Pancreas 8: 312-315, 1993.
• Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, and Kosaka K: Immunogenic and clinical characterization of slowly progressive insulin-dependent diabetes mellitus. Diabetes Care 16: 780-788, 1993.
• Ishibashi S, Mori N, Shimada M, Oka T, Shimano H, Gotoda T, Komeda K, Kawazu S, Murase T, Yazaki Y, and Yamada N: Apolipoprotein E metabolism in sciatic nerves of diabetes rats: Implication for diabetic neuropathy. Horm Metab Res 25: 82-87, 1993.
• Nakanishi K, Kobayashi T, Murase T, Nakatsuji T, Inoko H, Tsuji K, and Kosaka K: Association of HLA-A24 with complete β-cell destruction in insulin-dependent diabetes mellitus. Diabetes 42: 1086-1093, 1993.
• Hiraga T, Okubo M, Kobayashi T, Nakanishi K, Sugimoto T, and Murase T: Serum lipoprotein(a) levels differ in different phenotypes of primary hyperlipoproteinemia. Metabolism 42: 1327-1330, 1993.
• Inoue S, Satoh S, Tanaka K, Takamura Y, and Murase T: Determinants of fasting hypertriglyceridemia in ventromedial hypothalamic obesity in rats. Amer J Physiol 265: R786-R791, 1993.
• Tsutsumi K, Inoue Y, Shima A, Iwasaki K, Kawamura M, and Murase T: The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis. J Clin Invest 92: 411-417, 1993.
• Hiraga T, Shimokawa K, Murase T, and Yokoyama M: Reduction of serum lipoprotein(a) by estrogen in men with prostatic cancer. Endocr J 40: 507-513, 1993.
• Oka Y, Katagiri H, Yazaki Y, Murase T, and Kobayashi T: Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 342: 527-528, 1993.
• Nakanishi K, Kobayashi T, Miyashita H, Okubo M, Sugimoto T, Murase T, Hashimoto M, Fukuchi S, and Kosaka K: Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Amer J Gastroenterol 89: 762-766, 1994.
• Ohbayashi A, Hiraga T, Okubo M, Murase T, Matsushita H, and Hara M: Characteristics of porcine coronary artery endothelial cells in culture: comparison with aortic endothelium. Biochem Biophys Res Commun 202: 504-511, 1994.
• Nakanishi K, Kobayashi T, Murase T, and Kosaka K: Lack of association of the transporter associated with antigen processing with Japanese insulin-dependent diabetes mellitus. Metabolism 43: 1013-1017, 1994.
• Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, and Murase T: A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J Atheroscler Thromb 1: 30-36, 1994.
• Hiraga T, Kobayashi T, Okubo M, Nakanishi K, Sugimoto T, Ohashi Y, and Murase T: Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 18: 241-244, 1995.
• Tsutsumi K, Inoue Y, Shima A, and Murase T: Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agent, in STZ-induced diabetic rats. Diabetes 44: 414-417, 1995.
• Kajio H, Kobayashi T, Nakanishi K, Okubo M, Tsukada T, Nakayama T, Yamada N, Murase T, Yazaki Y, and Kosaka K: Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: β-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients. Metabolism 44: 869-875, 1995.
• Nakanishi K, Kobayashi T, Inoko H, Tsuji K, Murase T, and Kosaka K: Residual β-cell function and HLA-A24 in IDDM: markers of glycemic control and subsequent development of diabetic retinopathy. Diabetes 44: 1334-1339, 1995.
• Hiraga T, Shimada M, Okubo M, Nakanishi K, Kobayashi T, and Murase T: Lipoprotein(a) is an independent risk factor for multiple cerebral infarction. Atherosclerosis 122: 29-32, 1996.
• Kobayashi T, Nakanishi K, Murase T, and Kosaka K: Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45: 622-626, 1996.
• Takahashi S, Oida K, Okubo M, Suzuki J, Kohno M, Murase T, Yamamoto T, Nakai T: Very low density lipoprotein receptor binds apolipoprotein E2/2 as well as apolipoprotein E3/3. FEBS Letters 386: 197-200, 1996.
• Okubo M, Aoyama Y, and Murase T: A novel donor splice site mutation in the glycogen debranching enzyme gene is associated with glycogen storage disease type III. Biochem Biophys Res Commun 224: 493-499, 1996.
• Teramoto T, Yamada N, Shimano H, Oka Y, Itakura H, Saito Y, Morisaki N, Shirai K, Ishikawa T, Tada N, Ito H, Yamanouchi T, Kawakami M, Murase T, Okubo M, Totsuka Y, and Kikuchi M: Dose-dependent effect of niceritrol of plasma lipoprotein-a. Scand J Clin Lab Invest. 56: 359-365, 1996.
• Kobayashi T, Nakanishi K, Okubo M, Murase T, and Kosaka K: GAD antibodies seldom disappear in slowly progressive IDDM. Diabetes Care 19: 1031, 1996.
• Kobayashi T, Oka Y, Katagiri H, Falorni A, Kasuga A, Takai I, Nakanishi K, Murase T, and Kosaka K: Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia 39: 1196-1200, 1996.
• Hiraga T, Shimada M, Tsukada T, and Murase T: Hypertiglycridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system. Horm Metab Res 28: 603-606, 1996.
• Okubo M, Aoyama Y, Shio H, Albers J J, and Murase T: A novel missense mutation (Asn5 →Ile) in lecithin: cholesterol acyltransferase (LCAT) gene in a Japanese patient with LCAT deficiency. Int J Clin Lab Res 26: 250-254, 1996.
• Okubo M, Aoyama Y, Kishimoto M, Shishiba Y, and Murase T: Identification of a point mutation (G727T) in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type la, and carrier screening in healthy volunteers. Clin Genet 51: 179-183, 1997.
• Okubo M, Hasegawa Y, Aoyama Y, and Murase T: A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency: A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient. Atherosclerosis 130: 153-160, 1997.
• Tsutsumi K, Inoue Y, Hara A and Murase T: The novel compound NO-1886 elevates plasma high density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase without any effect on cholesteryl ester transfer protein activity. Metabolism 46: 257-260, 1997.
• Honda K, and Murase T: Effects of apolipopotein E phenotype on serum cholesterol level and cholesterol response to diet therapy in patients with hypercholestrolemia. Endocr J 44: 425-429, 1997.
• Kobayashi T, Nakanishi K, Nakase H, Kajio H, Okubo M, Murase T, and Kosaka K: In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. Diabetes 46: 1567-1571, 1997.
• Inoue Y, Nakanishi K, Hiraga T, Okubo M, Murase T, Kosaka K, Miyakoshi S, Mutoh Y, and Kobayashi T: Recovery of pancreatic β-cell function in hemochromatosis: Combined treatment with recombinant human erythropoietin and phlebotomy. Am J Med Sci 314: 401-402, 1997.
• Okubo M, Horinishi A, Nakamura N, Aoyama Y, Hashimoto M, Endo Y, and Murase T: A novel point mutation in an acceptor splice site of intron 32 (IVS 32A-12→G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. Hum Genet 102: 1-5, 1998.
• Okubo M, Aoyama Y, Harada K, Fukawa M, Tsukada T, Mokuno H, Yamada N, and Murase T: A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis. Atherosclerosis 140: 187-190, 1998.
• Okubo M, Inoue S, Horinishi A, Ogihara T, Kaneko K, Gotoda T, Yamada N, and Murase T: Detection of a new compound heterozygote (del G916/G1401A) for lipoprotein lipase deficiency and a comparative haplotype analysis of the mutant lipoprotein lipase gene from Japanese patients. Atherosclerosis 144: 443-447, 1999.
• Okubo M, Horinishi A, Hamada K, and Murase T: 1176C Polymorphism in Japanese patients with glycogen storage disease type 1a. Hum Genet 104: 193, 1999.
• Nakanishi K, Kobayashi T, Murase T, Naruse T, Nose Y, and Inoko H: Human leukocyte antigen-A24 and -DQA*0301 in Japanese insulin-dependent diabetes mellitus: Independent contributions to susceptibility to the disease and additive contributions to acceleration of β-cell destruction. J Clin Endocrinol Metab 84: 3721-3725, 1999.
• Arai T, Tsukada T, Okubo M, Murase T, and Matsumoto K: Ser477 Stop mutation of the lipoprotein lipase gene occurs at a higher frequency in Japanese subjects with normal triglyceride levels than in hypertriglyceridemic patients. Atherosclerosis 147: 417-420, 1999.
• Okubo M, Kanda F, Horinishi A, Takahashi K, Okuda S, Chihara K, and Murase T: Glycogen storage disease type IIIa: First report of a causative missense mutation (G1448R) in the glycogen debranching enzyme found in a homozygous patients. Hum Mut 14: 542-544, 1999.
• Okubo M, Horinishi A, Takeuchi M, Suzuki Y, Sakura N, Hasegawa Y, Igarashi T, Goto K, Tahara H, Uchimoto S, Omichi K, Kanno H, Hayasaka K, and Murase T: Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan. Hum Genet 106: 108-115, 2000.
• Tsutsumi K, Inoue Y, and Murase T: Effects of NO-1886, a lipoprotein lipase promoting agent, on homozygous and heterozygous Watanabe heritable hyperlipidaemic rabbits. Arzneim-Forsch /Drug Res 50: 118-121, 2000.
• Okubo M, Horinishi A, Suzuki Y, Murase T, and Hayasaka K: Compound heterozygous patient with glycogen storage disease type III: Identification of two novel AGL mutations, a donor splice site mutation of Chinese origin and a 1-bp deletion of Japanese origin. Am J Med Genet 93: 211-214, 2000.
• Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Murase T, Hashimoto M, and Takeuchi K: Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 356: 910-911, 2000.
• Tanaka S, Kobayashi T, Kawanami D, Hori A, Okubo M, Nakanishi K, Katori H, and Murase T: Paradoxical glucose infusion for hypernatraemia in diabetic hyperglycaemic hyperosmolar syndrome. J Intern Med 248: 165-169, 2000.
• Kobayashi T, Kawabata M, Tanaka S, Maehara M, Mishima A, and Murase T: Methemoglobinemia induced by combined use of sodium nitrate and acetoaminophen. Intern Med 39: 860, 2000.
• Horinishi A, Murase T, and Okubo M: Novel intronic polymorphism (IVS6-73A/G and IVS21+124A/G) in the glycogen-debranching enzyme (AGL) gene. Hum Mut 16: 279, 2000.
• Tanaka S, Kobayashi T, Tomura H, Okubo M, Nakanishi K, Takeda J, and Murase T: A novel dominant-negative mutation of the hepatocyte nuclear factor-1α gene in Japanese early-onset type 2 diabetes. Horm Metab Res 32: 373-377, 2000.
• Arai T, Tsukada T, Murase T, Matsumoto K: Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency. Clin Chim Acta 301: 103-117, 2000.
• Oki Y, Okubo M, Tanaka S, Nakanishi K, Kobayashi T, and Murase T: Diabetes mellitus secondary to glycogen storage disease type III. Diabetic Med 17: 810-812, 2000.
• Yoshida T, Gotoda T, Okubo M, Iizuka Y, Ishibashi S, Kojima T, Murakami T, Murase T, and Yamada N: A Japanese patient with lipoprotein lipase deficiency homozygous for the Gly188Glu mutation prevalent worldwide. J Atheroscler Thromb 7: 45-49, 2000.
• Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Murase T, Hashimoto M, Watanabe G, Matsushita H, Endo Y, Yoshizaki H, Kosuge T, Sakamoto M, and Takeuchi K: Evidence of primary β-cells destruction by T-cells and β-cell differentiation from pancreatic ductal cells in diabetes associated with active autoimmune chronic pancreatitis. Diabetes care 24: 1661-1667, 2001.
• Ebara T, Okubo M, Horinishi A, Adachi M, Murase T , and Hirano T: No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61→Stop) in the lipoprotein lipase gene. Atherosclerosis 159: 375-379, 2001.
• Okubo M, Tsurukubo Y, Higaki T, Kawabe T, Goto M, Murase T, Ide T, Furuichi Y, and Sugimoto M: Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr Virus. Cancer Genet Cytogen 129: 873-874, 2001.
• Hayakawa M, Okubo M, Katori H, Nagahama K, Murase T, Kobayashi T, Tanaka S, Nakanishi K, Odawara M, Matsushita H, and Yamada A: A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy. Am J Kidney Dis 39: (E15) 1-4, 2002.
• Tanaka S, Kobayashi T, Nakanishi K, Koyama R, Okubo M, Murase T, Odawara M, and Inoko H: Association of HLA-DQ genotype in autoantibody-negative and rapid-onset type1 diabetes. Diabetes Care 25: 2302-2307, 2002.
• Sone H, Katagiri A, Ishibashi S, Abe R, Saito Y, Murase T, Yamashita H, Yajima Y, Ito H, Ohashi Y, Akanuma Y, Yamada, and JDC Study Group: Effects of lifestyle modifications on patients with type 2 diabetes: The Japan Diabetes Complications Study (JDCS) study design, baseline analysis and three year-interim report. Horm Metab Res 34: 509-515, 2002.
• Horinishi A, Okubo M, Tang NL, Hui J, To KF, Mabuchi T, Okada T, Mabuchi H, and Murase T: Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III. J Hum Genet 47: 55-59, 2002.
• Okubo M, Horinishi A, Kim DH, Yamamoto TT, and Murase T: Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene. Hum Mutation 19: 186, 2002.
• Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, Takada S, Kim DH, Ioka RX, Ono M, Tomoyori H, Okubo M, Murase T, Kamataki A, Yamamoto J, Magoori K, Takahashi S, Miyamoto Y, Oishi H, Nose M, Okazaki M, Usui S, Imaizumi K, Yanagisawa M, Sakai J, and Yamamoto TT: Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci USA 100: 229-234, 2003.
• Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, and Lernmark A: Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 88: 4768-4775, 2003.
• Amemiya-Kudo M, Oka J, Ide T, Matsuzaka T, Sone H, Yoshikawa T, Yahagi N, Ishibashi S, Osuga J, Yamada N, Murase T, Shimano H: Sterol regulatory element-binding proteins activate insulin gene promoter directly and indirectly through synergy with BETA2/E47. J Biol Chem 280: 34577-34589, 2005.
• Endo Y, Fateen E, Aoyama Y, Horinishi A, Ebara T, Murase T, Shin YS, Okubo M: Molecular characterization of Egyptian patients with glycogen storage disease type IIIa. J Hum Genet 50: 538-542, 2005.
• Endo Y, Horinishi A, Vorgerd M, Aoyama Y, Ebara T, Murase T, Odawara M, Podskarbi T, Shin YS, Okubo M: Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. J Hum Genet 51: 958-963, 2006.
• Murase T, Okubo M, Amemiya-Kudo M, Hiraga T, Oka J, Shimada M, Igarashi T: Impact of markedly elevated serum lipoprotein(a) levels (≥100mg/dl) on the risk of coronary heart disease. Metabolism 56: 1187-1191, 2007.
• Okubo M. Horinishi A, Saito M, Ebara T, Endo Y, Kaku K, Murase T, Eto M: A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency. Mol Genet Metab 92: 229-233, 2007.
• Ebara T, Endo Y, Yoshiike S,Tsuji M, Taguchi S, Murase T, Okubo M: A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis. Clin Chim Acta 386: 100-104, 2007.
• Ogimoto A, Okudo M, Okayama H, Shin YS, Endo Y, Ebara T, Inoue K, Ohtsuka T, Tahara H, Murase T, Higashi J: A Japanese patient with cardiomyopathy caused by a novel mutation R285X in the AGL gene. Circ J 71: 1653-1656, 2007.
• Murase T, Okubo M, Michiyo-Amemiya M, Ebara T, Mori Y: Impact of elevated serum lipoprotein(a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus. Metabolism 57: 791-795, 2008.
• Ebara T, Murase T, Okubo M: Is LPL deficiency atherogenic? Circ Res 102: e118, 2008.
• Ebara T, Murase T, Okubo M: Pancreatitis caused by hypertriglyceridemia in a patient compound heterozygous for Leu334Phen and －514C→T in the hepatic lipase gene. Pancreas 38: 233-235, 2009.
• Okubo M, Ishihara M, Iwasaki T, Ebara T, Aoyama Y, Murase T, Hattori H: A novel APOA5splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient. Atherosclerosis 207:24-25, 2009.
• Endo Y, Fateen E, EI Shabrawy M, Aoyama Y, Ebara T, Murase T, Podskarbi T, Shin YS, Okubo M: Egyptian glycogen storage disease type III – identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId. Clin Chem Lab Med 47(10): 1233-8, 2009.
• Aoyama Y, Ozer I, Demirkol M, Ebara T, Murase T, Podskarbi T, Shin YS, G, Gökçay G, Okubo M: Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations. J Hum Genet 54(11): 681-6, 2009.
• Aoyama Y, Endo Y, Ebara T, Murase T, Shin YS, Podskarbi T, Ozer I, Demirkol M, Gökçay G, Okubo M: Novel AGL mutation in a Turkish patient with glycogen storage disease type IIIa. Pediatr Intern 52(1): 145-147, 2010.
• Murase T, Okubo M, Takeuchi I: Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for Type III hyperlipoproteinemia. J Clin Lipidol 4: 99-104, 2010.
• Hsieh SD, Muto T, Tsuji H, Arase Y, Murase T: Clustering of other metabolic risk factors in subjects with metabolic syndrome. Metabolism 59: 697-702, 2010.
• Hsieh SD, Ashwell M, Muto T, Tsuji H, Arase Y, Murase T: Urgency of reassessment of obesity indices for metabolic risks. Metabolism 59: 834-840, 2010.
• Ebara T, Hattori H, Murase T, Okubo M: Reduced plasma apolipoprotein A-V concentrations in two lecithin:cholesterol acyltransferase deficient patients. Clin Chem Lab Med 48: 1359-1360, 2010.
• Hsieh SD, Muto T, Murase T, Tsuji H, Arase Y:　Eating until feeling full and rapid eating both increase metabolic risk factors in Japanese men and women. Public Health Nutr 14: 1266-1269, 2011.
• Amemiya-Kudo M, Oka J, Takeuchi Y, Okazaki H, Yamamoto T, Yahagi N, Matsuzaka K, Okazaki S, Osuga JI, Yamada N, Murase T, Shimano H: Suppression of the pancreatic duodenal homeodomain transcription-1(PDX-1) promoter by sterol regulation element-binding protein-1c (SREBP-1c). J Biol Chem 286: 27902-27914,2011.
• Kinpara K, Okada H, Yoneyama A, Okubo M, Murase T: Lipoprotein(a)-cholesterol: a significant component of serum cholesterol. Clin Chim Acta 412:1783－1787, 2011.
• Hsieh SD, Muto T, Murase T, Tsuji H, Arase Y: Association of short sleep duration with obesity, diabetes, fatty liver and behavioral factors in Japanese men. Intern Med 50:2499-2501, 2011.
• Shingo AS, Kanabayashi T, Murase T, Kito S: Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signalling through the dentate gyrus. Behav Brain Res 229: 378-383, 2012.
• Murase T, Arimoto S, Okubo M, Morinaga S: Significant reduction of elevated serum lipoprotein (a) concentrations during levo-thyroxine-replacement therapy in a hypothyroid patients. J Clin Lipidol 6: 388-391, 2012.
• Hsieh SD, Muto T, Murase T, Tsuji H, Arase Y: Both eating till feeling full and rapid eating are associated with clustering of psychosomatic problems and preference for strong tastes. Obes ResClin Pract 6: e308-e313, 2012.
• Murase T, Ebara T, Okubo M: Hepatic lipase activity is decreased in Japanese patients with type III hyperlipoproteinemia. Clin Chim Acta 414: 185-187, 2012.
• Shingo AS, Kanabayashi T, Kito S, Murase T: Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats. Behav Brain Res. 241: 105-11. 2013.
• Kondo Y, Usui H, Ishige-Wada M, Murase T, Owada M, Okubo M: Liver cirrhosis treated by living donor transplantation in a patient with AGL mutation c.2607-2610delATTC and c.1672dupA. Clin chim Acta 424: 10-21, 2013.
• Murase T, Ebara T, Okubo M: Lipoprotein lipase activity in heterozygotes for lipoprotein lipase gene mutations reveals a gender bias. Ann Clin Biochem.51: 294-297, 2014.
• Okubo M, Toromanovic A, Ebara T, Murase T: Apolipoprotein CIITuzla: A novel large deletion in APOC2 caused by Alu-Alu homologous recombination in an infant with apolipoprotein C-II deficiency. Clin Chim Acta 438: 148-153, 2015.
• Okubo M, Ucar SK, Podskarbi T, Murase T, Shin YS, Coker M: Molecular and　clinical delineation of 12 patients with glycogen storage disease type III in　Western Turkey. Clin Chim Acta 439: 162-167, 2015.
• Shingo AS, Mervis T, Kanabayashi T, Kito S, Murase T: The dendrites of granule cell layer neurons are the primary injury sites in the " Brain Diabetes" rat. Behav Brain Res 280: 78-83, 2015.

(Original papers published in peer-reviewed journals)

• Murase T, Saito T, and Yoshida S: Studies on radioimmunoassay for arginine vasopressin. Med J Osaka Univ 21: 131-136, l971.
• Mochizuki S, Murase T, Yamaoka H, Ishiki M, Tada N,and Nagano M: Lipoprotein lipase activity in ischaemic and anoxic myocardium. Basic Res in Cardiol 82 (Suppl 1): 45-52, 1987.
• Kawakami M, Watanabe N, Ogata H, Murase T, Yamada N, Sando H, Shibata S, Oda T, and Takaku F: Specificity in metabolic effects of cachectin/TNF and other related cytokins. Ann NY Acad Sci 587: 339-350, 1990.
• Mokuno H, Yamada N, Sugimoto T, Kobayashi T, Ishibashi S, Shimano H, Murase T, and Takaku F: Cholesterol-free diet in heterozygous familial hypercholesterolemia. Ann NY Acad Sci 598: 525-526, 1990.
• Yamada N, Yoshinaga H, Gotoda T, Harda K, Shimada M, Osuga J, Akanuma Y, and Murase T: Plasma lipid abnormalities and risk factors for coronary artery disease in Japanese subjects with diabetes mellitus and glucose intolerance. Diab Res Clin Pract 24: S215-S220, 1994.
• Okubo M, and Murase T: Hypertriglyceridemia and low HDL cholesterol in Japanese patients with NIDM. Diabetes 45 (Suppl 3): S123-S125, 1996.
• Ito H, Harano Y, Suzuki M, Hattori Y, Takeuchi M, Inada H, Inoue J, Kawamori R, Murase T, Ouchi Y, Umeda F, Nawata H, Orimo H, and the Multiclinical Study for Diabetic Macroangiopathy Group: Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Diabetes 45 (Suppl 3): S19-S23, 1996.
• Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Odawara M, Mutase T, Hashimoto M, Watanabe G, Matsushita H, Inoko H, and Takeuchi K: Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis: pathological examinations of the endocrine and exocrine pancreas. Ann NY Acad Sci 958: 152-9, 2002.
• Murase T, Okubo M: Search for a useful biochemical index to screen for type III hyperlipoproteinemia.　International Atherosclerosis Society (IAS) Commentaries (Invited) http://www.athero.org/commentaries/October 8, 2010.

• Yoshida S, Saito T, Murase T: Control of vasopressin secretion. In: Neuroendocrine Controls (Yagi K, Yoshida S, eds), Univ Tokyo Press, 1973, p189-204.
• Nakai T, Oida K, Miyabo S, Yamada N, Murase T: Augmentation of hyper- cholesterolemia in the streptozotocin-induced diabetic rats fed a high cholesterol diet. In: Current topics in clinical and experimental aspects of diabetes (Sakamoto N, Min HK, Baba S, eds), Elsevier Science Publishers, 1985, p166-172.
• Mochizuki S, Murase T, Yamaoka H, Ishiki N, Tada N, Nagano M: Lipoprotein Lipase activity in ischaemic and anoxic myocardium. In: Lipoprotein metabolism in the normoxic and ischaemic heart (StamH, van der Vusse, eds), Steinkopff Verlag Darmstadt, 1986, p45-52.
• Murase T, Takahashi K, Ishibashi S, Mori N, Shimano H, Yamaoka H, Mochizuki S: Triglyceride lipase activities in experimental diabetes. In: The International Symposium on ATHEROSCLEROSIS IN DIABETES MELLITUS in Osaka, 1986. Medical Journal-sha, 1987, p151-154.
• Murase T, Mochizuki S, Yamaoka H, Nagano M: Lipoprotein lipase activity in isolated perfused hearts of streptozotocin-induced diabetic rats. In: The Diabetic Heart (Nagano M, Dhalla NS, eds), Raven Press, 1991, p409-413.
• Okubo M, Kobayashi T, Nakanishi K, Sugimoto T, Kosaka K, Murase T: The significance of lipoprotein(a) in non-insulin-dependent diabetes mellitus.In: New directions in research and clinical works for obesity and diabetes mellitus (Sakamoto N, Angel A, Hotta N, eds), Elisevier Science Publishers, 1991, p341-347.
• Gotoda T, Yamada N, Murase T, Harada K, Shimada M, Furuichi Y, Takaku F:Molecular analysis of the lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. In: Molecular Approaches to the Study and Treatment of Human Diseases (Yoshida TO, Wilson JM, eds), Elsevier Science Publishers, 1992, p37-43.
• Hiraga T, Murase T, Tsukada T: Blood coagulation and fibrinolysis in patients with hypertriglyceridemia. In: Triglycerides and Atherosclerosis (Yamamoto A, Nakamura H, Nakai T, eds), Churchill Livingstone Japan, 1994, p109-114.
• Murase T: Hypertriglyceridemia and low HDL-cholesterol in diabetes Mellitus .In:Triglycerides and Atherosclerosis (Yamamoto A, Nakamura H, Nakai T, eds), Churchill Livingstone Japan, 1994, p135-139.
• Okubo M, Murase T: Glycogen-debranching enzyme. In: Wiley Encyclopedia of Molecular Medicine, John Wiley & Sons, Inc., 2002, p1488-1489.